Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

NGM Biopharmaceuticals Inc buy B. Riley

Start price
€0.63
22.11.23 / 50%
Target price
€3.22
22.11.24
Performance (%)
125.60%
End price
-
23.11.24
Summary
This prediction is currently being closed. With a performance of 125.60% the BUY prediction by B__Riley is a big success. B__Riley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
NGM Biopharmaceuticals Inc - - -
iShares Core DAX® 1,30 % -1,39 % 12,26 %
iShares Nasdaq 100 0,61 % -4,17 % 1,69 %
iShares Nikkei 225® 8,77 % 9,78 % 30,04 %
iShares S&P 500 0,25 % -2,30 % 0,79 %

Comments by B__Riley for this prediction

In the thread NGM Biopharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 125.60%
Target price 3.220
Change
Ends at 22.11.24

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target lowered by analysts at B. Riley from $7.00 to $3.50. They now have a "buy" rating on the stock.
Ratings data for NGM provided by MarketBeat

In the thread Trading NGM Biopharmaceuticals Inc
Prediction Buy
Perf. (%) 125.60%
Target price 3.220
Change
Ends at 22.11.24

Die von B__Riley gewählte maximale Laufzeit wurde überschritten